250 related articles for article (PubMed ID: 2669913)
21. Towards understanding the kallikrein-kinin system: insights from measurement of kinin peptides.
Campbell DJ
Braz J Med Biol Res; 2000 Jun; 33(6):665-77. PubMed ID: 10829095
[TBL] [Abstract][Full Text] [Related]
22. The kallikrein-kinin system as a regulator of cardiovascular and renal function.
Rhaleb NE; Yang XP; Carretero OA
Compr Physiol; 2011 Apr; 1(2):971-93. PubMed ID: 23737209
[TBL] [Abstract][Full Text] [Related]
23. Developmental regulation of ACE gene expression by endogenous kinins and angiotensin II.
Yosipiv IV; el-Dahr SS
Am J Physiol; 1995 Aug; 269(2 Pt 2):F172-9. PubMed ID: 7544538
[TBL] [Abstract][Full Text] [Related]
24. Do angiotensin converting enzyme inhibitors lower blood pressure in the rat partly via the humorally mediated antihypertensive system of the renal medulla?
Karlström G; Arnman V; Bergström G; Bohman SO; Rudenstam J; Göthberg G
J Hypertens; 1990 Jun; 8(6):501-13. PubMed ID: 2165084
[TBL] [Abstract][Full Text] [Related]
25. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
Nagai N; Oike Y; Izumi-Nagai K; Koto T; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Ishida S
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297
[TBL] [Abstract][Full Text] [Related]
26. Evidence for participation of kinins in the antihypertensive effect of converting enzyme inhibition.
Overlack A; Stumpe KO; Kühnert M; Kolloch R; Ressel C; Heck I; Krück F
Klin Wochenschr; 1981 Jan; 59(2):69-74. PubMed ID: 6163004
[TBL] [Abstract][Full Text] [Related]
27. Disappearance of bradykinin in the renal circulation of dogs. Effects of kininase inhibition.
Nasjletti A; Colina-Chourio J; McGiff JC
Circ Res; 1975 Jul; 37(1):59-65. PubMed ID: 167999
[TBL] [Abstract][Full Text] [Related]
28. Role of bradykinin in the cardiac effects of angiotensin-converting enzyme inhibitors.
Linz W; Schölkens BA
J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S83-90. PubMed ID: 1282635
[TBL] [Abstract][Full Text] [Related]
29. ACE inhibition, endothelial function and coronary artery lesions. Role of kinins and nitric oxide.
Mombouli JV
Drugs; 1997; 54 Suppl 5():12-22. PubMed ID: 9429841
[TBL] [Abstract][Full Text] [Related]
30. Apstatin, a selective inhibitor of aminopeptidase P, reduces myocardial infarct size by a kinin-dependent pathway.
Wolfrum S; Richardt G; Dominiak P; Katus HA; Dendorfer A
Br J Pharmacol; 2001 Sep; 134(2):370-4. PubMed ID: 11564655
[TBL] [Abstract][Full Text] [Related]
31. Activity and functional significance of the renal kallikrein-kinin-system in polycystic kidney disease of the rat.
Braun C; Kleemann T; Hilgenfeldt U; Riester U; Rohmeiss P; van der Woude FJ
Kidney Int; 2002 Jun; 61(6):2149-56. PubMed ID: 12028455
[TBL] [Abstract][Full Text] [Related]
32. Angiotensin-converting enzyme inhibition modifies angiotensin but not kinin peptide levels in human atrial tissue.
Campbell DJ; Duncan AM; Kladis A
Hypertension; 1999 Aug; 34(2):171-5. PubMed ID: 10454436
[TBL] [Abstract][Full Text] [Related]
33. Endothelium-dependent effects of converting-enzyme inhibitors.
Vanhoutte PM; Boulanger CM; Illiano SC; Nagao T; Vidal M; Mombouli JV
J Cardiovasc Pharmacol; 1993; 22 Suppl 5():S10-6. PubMed ID: 7508046
[TBL] [Abstract][Full Text] [Related]
34. Kinin receptors of the central nervous system of spontaneously hypertensive rats related to the pressor response to bradykinin.
Martins DT; Fior DR; Nakaie CR; Lindsey CJ
Br J Pharmacol; 1991 Aug; 103(4):1851-6. PubMed ID: 1655143
[TBL] [Abstract][Full Text] [Related]
35. Interference of converting enzyme inhibitors with the kallikrein-kinin system.
Carretero OA; Orstavik TB; Rabito SF; Scicli AG
Clin Exp Hypertens A; 1983; 5(7-8):1277-85. PubMed ID: 6315269
[TBL] [Abstract][Full Text] [Related]
36. Converting enzyme inhibition in kinin-deficient brown Norway rats.
Danckwardt L; Shimizu I; Bönner G; Rettig R; Unger T
Hypertension; 1990 Oct; 16(4):429-35. PubMed ID: 2145220
[TBL] [Abstract][Full Text] [Related]
37. Role of kinins in the acute antihypertensive effect of the converting enzyme inhibitor, captopril.
Carretero OA; Miyazaki S; Scicli AG
Hypertension; 1981; 3(1):18-22. PubMed ID: 6259058
[TBL] [Abstract][Full Text] [Related]
38. Acute renal hemodynamic effects of ACE inhibition in diabetic hyperfiltration: role of kinins.
Komers R; Cooper ME
Am J Physiol; 1995 Apr; 268(4 Pt 2):F588-94. PubMed ID: 7733315
[TBL] [Abstract][Full Text] [Related]
39. Effect of new peptide inhibitors on the ratio of angiotensin I-converting and kinin-degrading activities of dipeptidyl carboxypeptidase (angiotensin-converting enzyme).
Kalinina EV; Posdnev VF; Komissarova NV; Gomazkov OA
Biochemistry (Mosc); 1997 Mar; 62(3):247-50. PubMed ID: 9275297
[TBL] [Abstract][Full Text] [Related]
40. Role of the kallikrein-kinin system in the renal effects of angiotensin-converting enzyme inhibition in anaesthetized dogs.
Clappison BH; Anderson WP; Johnston CI
Clin Exp Pharmacol Physiol; 1981; 8(5):509-13. PubMed ID: 6276063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
